Boston Children’s Hospital:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Boston Children's Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0501
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Boston Children’s Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organization provides specialty services such as cardiovascular surgery, digestive care, blood diseases, fetal care and others. Its Advanced Fetal Care Center supports the needs of families and referring physicians at all steps of care for various congenital anomalies, from diagnosis and counseling through treatment and follow-up. It also collaborates with other institutes such as Harvard Stem Cell Institute, MIT Health Sciences & Technology, the Broad Institute, the Autism Consortium and Boston University. Boston Children’s is headquartered in Boston, Massachusetts, the US.

Boston Children’s Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Boston Children’s Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Boston Children’s Hospital, Medical Devices Deals, 2012 to YTD 2018 10
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
ClearPath Vaccines and Astellas Pharma Enter into Research Agreement with Boston Children’s Hospital 13
Amgen Enters into Research Agreement with Boston Children’s Hospital 14
Boston Children’s Hospital Enters into Agreement with GE Healthcare 15
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 16
Gruenenthal, Proteus and Boston Children’s Hospital Enter into Agreement 17
Grunenthal Enters into Agreement with Proteus and Boston Children’s Hospital 18
Fate Therapeutics Enters into Research Agreement with Boston Children’s Hospital 19
Boston Children’s Hospital Enters Into Co-Development Agreement With Abwiz Bio 20
Shire Enters Into Co-Development Agreement With Boston Children’s Hospital For Pediatric Therapies 21
Life Technologies Enters Into Co-Development Agreement With Boston Children’s Hospital 22
Merger 23
Warren Hospital Merges With St. Luke’s Hospital 23
Licensing Agreements 24
Cambridge Epigenetix Enters into Licensing Agreement with Boston Children’s Hospital 24
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 25
Scholar Rock Enters into Licensing Agreement with Boston Children’s Hospital 26
Boston Children’s Hospital – Key Competitors 27
Boston Children’s Hospital – Key Employees 28
Boston Children’s Hospital – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Joint Venture 34
Recent Developments 35
Strategy And Business Planning 35
May 01, 2017: Boston Orthotics & Prosthetics Adds a Second Clinic in Waltham, MA 35
Government and Public Interest 36
May 11, 2018: Trial shows chemotherapy is helping kids live with pulmonary vein stenosis 36
Apr 04, 2018: A new tactic for antibiotic-resistant pneumonia: Making neutrophils stronger, but fewer in number 38
Apr 02, 2018: Two-drug approach halts lung tumors by starving them metabolically 39
Jan 25, 2018: Cancer researchers hit a bullseye with a new drug target for Ewing sarcoma 41
Jan 10, 2018: Robotic implants spur tissue regeneration inside the body 43
Dec 06, 2017: Routing gene therapy directly into the brain 44
Nov 07, 2017: Boston Children’s Hospital Receives Grant to Support Malaria Research and Music Therapy Program Honoring Dr. Gary Loveman 46
Aug 14, 2017: Breakthrough Study By Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice 47
Jul 06, 2017: NIH and Collaborators Identify the Genomic Cause for Carey-Fineman-Ziter Syndrome 48
May 12, 2017: Researchers find key molecule that could lead to new therapies for anemia 50
Mar 20, 2017: New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials 52
Product News 53
Jul 17, 2018: Skewed T-cell pathway may help explain transplant rejection, autoimmune diseases 53
Jan 31, 2018: Sickle cell gene therapy to boost fetal hemoglobin: A 70-year timeline of discovery 56
Other Significant Developments 57
Jan 15, 2018: Multidisciplinary care to treat severe asthma 57
Dec 13, 2017: Care.com and AARP Announce the Launch of the Care Institute to Support the Nation’s Care Workforce and Meet the Rising Demand for Care 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
Boston Children's Hospital, Pharmaceuticals & Healthcare, Key Facts 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Boston Children's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Boston Children's Hospital, Deals By Therapy Area, 2012 to YTD 2018 9
Boston Children's Hospital, Medical Devices Deals, 2012 to YTD 2018 10
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ClearPath Vaccines and Astellas Pharma Enter into Research Agreement with Boston Children's Hospital 13
Amgen Enters into Research Agreement with Boston Children's Hospital 14
Boston Children's Hospital Enters into Agreement with GE Healthcare 15
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 16
Gruenenthal, Proteus and Boston Children's Hospital Enter into Agreement 17
Grunenthal Enters into Agreement with Proteus and Boston Children's Hospital 18
Fate Therapeutics Enters into Research Agreement with Boston Children's Hospital 19
Boston Children's Hospital Enters Into Co-Development Agreement With Abwiz Bio 20
Shire Enters Into Co-Development Agreement With Boston Children's Hospital For Pediatric Therapies 21
Life Technologies Enters Into Co-Development Agreement With Boston Children's Hospital 22
Warren Hospital Merges With St. Luke's Hospital 23
Cambridge Epigenetix Enters into Licensing Agreement with Boston Children’s Hospital 24
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 25
Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 26
Boston Children's Hospital, Key Competitors 27
Boston Children's Hospital, Key Employees 28
Boston Children's Hospital, Key Employees (cont..) 31
Boston Children's Hospital, Other Locations 33
Boston Children's Hospital, Subsidiaries 33
Boston Children's Hospital, Joint Venture 34

List of Figures
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Boston Children's Hospital, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Boston Children’s Hospital:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Daya Materials Bhd (DAYA):企業の財務・戦略的SWOT分析
    Summary Daya Materials Bhd (DMB) is a chemical company that offers polymer compound solutions. The company provides bulk chemicals, catalysts, additives, inert support materials and deodorizing agents. Its polymer compound products include semi conductive compounds, medium-voltage XLPE compounds, lo …
  • Discovery Inc (DISCA):企業の財務・戦略的SWOT分析
    Discovery Inc (DISCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nationwide Building Society:企業の戦略・SWOT・財務分析
    Nationwide Building Society - Strategy, SWOT and Corporate Finance Report Summary Nationwide Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Briggs & Stratton Corporation:企業の戦略・SWOT・財務分析
    Briggs & Stratton Corporation - Strategy, SWOT and Corporate Finance Report Summary Briggs & Stratton Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Tyson Fresh Meats Inc:戦略・SWOT・企業財務分析
    Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Promius Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Promius Pharma LLC (Promius Pharma), a subsidiary of Dr. Reddy's Laboratories Ltd, is a designer of personal and practical health care solutions that provides dermatology and neurology products. The company provides dermatology and neurology products. Its products include clocortolone pivala …
  • Sunesis Pharmaceuticals Inc (SNSS):企業の財務・戦略的SWOT分析
    Sunesis Pharmaceuticals Inc (SNSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Sa Sa International Holdings Limited (178):企業の財務・戦略的SWOT分析
    Sa Sa International Holdings Limited (178) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Provectus Biopharmaceuticals Inc (PVCT):医療機器:M&Aディール及び事業提携情報
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Mayo Clinic:製薬・医療:M&Aディール及び事業提携情報
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • VertiFlex Inc:医療機器:M&Aディール及び事業提携情報
    Summary VertiFlex Inc (Vertiflex) is a medical device company that offers invasive treatments for lumbar stenosis. The company offers products such as interspinous spacer and direct decompression systems. Its interspinous spacer system is a motion-preserving, indirect decompression spinal implant sy …
  • Harman International Industries, Incorporated:企業のM&A・事業提携・投資動向
    Harman International Industries, Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Harman International Industries, Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • Alliant Energy Corporation (LNT)-エネルギー分野:企業M&A・提携分析
    Summary Alliant Energy Corporation (Alliant Energy) is an energy utility holding company. Through subsidiaries, it carries out generation and distribution of electricity and distribution and transportation of natural gas. The company operates through Interstate Power and Light Company (IPL) and Wisc …
  • LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報
    Summary LegoChem Biosciences Inc (LCB) is a biopharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of antib …
  • Chiyoda Corporation:企業の戦略・SWOT・財務情報
    Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report Summary Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Serinus Energy Plc (SEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Serinus Energy Plc (Serinus), formerly Serinus Energy Inc is an oil and gas company that explores and produces oil and natural gas products. The company explores, acquires and develops crude oil and natural gas reserves. It holds 100% interest in Satu Mare Concession located in the Eastern P …
  • Triple-S Management Corp (GTS):企業の財務・戦略的SWOT分析
    Triple-S Management Corp (GTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Euskaltel, S.A. (EKT):企業の財務・戦略的SWOT分析
    Euskaltel, S.A. (EKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nielsen Holdings PLC:企業の戦略・SWOT・財務分析
    Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sequella Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sequella Inc (Sequella) is a clinical-stage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company’s pipeline products comprise SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid antibiotic susceptibility test, B-SMART. S …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆